Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Clinical trial NCT06692452 · WITHDRAWN

Trial details

NCT number: NCT06692452
Sponsor: Eric Jacobsen, MD
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Peripheral T Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Enteropathy-Associated T-Cell Lymphoma Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

Start date: 2024-12-24
Primary completion: 2027-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.